Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 330

1.

Searching new structural scaffolds for BRAF inhibitors. An integrative study using theoretical and experimental techniques.

Campos LE, Garibotto FM, Angelina E, Kos J, Tomašič T, Zidar N, Kikelj D, Gonec T, Marvanova P, Mokry P, Jampilek J, Alvarez SE, Enriz RD.

Bioorg Chem. 2019 Jul 12;91:103125. doi: 10.1016/j.bioorg.2019.103125. [Epub ahead of print]

PMID:
31401373
2.

Plasma Cathepsin S is Associated with High-density Lipoprotein Cholesterol and Bilirubin in Patients with Abdominal Aortic Aneurysms.

Mirjanic-Azaric B, Vasic N, Cerne D, Kos J, Bogavac-Stanojevic N.

J Med Biochem. 2019 May 11;38(3):268-275. doi: 10.2478/jomb-2018-0039. eCollection 2019 Jul.

3.

Cystatins in cancer progression: More than just cathepsin inhibitors.

Breznik B, Mitrović A, T Lah T, Kos J.

Biochimie. 2019 May 7. pii: S0300-9084(19)30141-5. doi: 10.1016/j.biochi.2019.05.002. [Epub ahead of print] Review.

PMID:
31071357
4.

Design and synthesis of anticancer 1-hydroxynaphthalene-2-carboxanilides with a p53 independent mechanism of action.

Spaczyńska E, Mrozek-Wilczkiewicz A, Malarz K, Kos J, Gonec T, Oravec M, Gawecki R, Bak A, Dohanosova J, Kapustikova I, Liptaj T, Jampilek J, Musiol R.

Sci Rep. 2019 Apr 23;9(1):6387. doi: 10.1038/s41598-019-42595-y.

5.

Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease.

Meden A, Knez D, Jukič M, Brazzolotto X, Gršič M, Pišlar A, Zahirović A, Kos J, Nachon F, Svete J, Gobec S, Grošelj U.

Chem Commun (Camb). 2019 Mar 26;55(26):3765-3768. doi: 10.1039/c9cc01330j.

PMID:
30864579
6.

Increased cystatin F levels correlate with decreased cytotoxicity of cytotoxic T cells.

Prunk M, Nanut MP, Sabotic J, Svajger U, Kos J.

Radiol Oncol. 2019 Mar 3;53(1):57-68. doi: 10.2478/raon-2019-0007.

7.

Effect of Wheat Milling Process on the Distribution of Alternaria Toxins.

Janić Hajnal E, Mastilović J, Bagi F, Orčić D, Budakov D, Kos J, Savić Z.

Toxins (Basel). 2019 Mar 1;11(3). pii: E139. doi: 10.3390/toxins11030139.

8.

Relationship of High Circulating Cystatin C to Biochemical Markers of Bone Turnover and Bone Mineral Density in Elderly Males with a Chronic Heart Failure.

Nedeljkovic BB, Loncar G, Vizin T, Radojicic Z, Brkic VP, Kos J.

J Med Biochem. 2019 Mar 1;38(1):53-62. doi: 10.2478/jomb-2018-0011. eCollection 2019 Mar.

9.

Identification of Subject-Specific Immunoglobulin Alleles From Expressed Repertoire Sequencing Data.

Gadala-Maria D, Gidoni M, Marquez S, Vander Heiden JA, Kos JT, Watson CT, O'Connor KC, Yaari G, Kleinstein SH.

Front Immunol. 2019 Feb 13;10:129. doi: 10.3389/fimmu.2019.00129. eCollection 2019.

10.

Potential of Nanomaterial Applications in Dietary Supplements and Foods for Special Medical Purposes.

Jampilek J, Kos J, Kralova K.

Nanomaterials (Basel). 2019 Feb 19;9(2). pii: E296. doi: 10.3390/nano9020296. Review.

11.

Increased Plasma Cathepsin s at the Time of Percutaneous Transluminal Angioplasty is Associated with 6-months' Restenosis of the Femoropopliteal Artery.

Mijovski MB, Boc V, Fonovic UP, Marc J, Blinc A, Kos J, Cerne D.

J Med Biochem. 2018 Jan 1;37(1):54-61. doi: 10.1515/jomb-2017-0033. eCollection 2018 Jan.

12.

Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson's Disease.

Pišlar A, Tratnjek L, Glavan G, Živin M, Kos J.

Front Mol Neurosci. 2018 Nov 2;11:412. doi: 10.3389/fnmol.2018.00412. eCollection 2018.

13.

Localization patterns of cathepsins K and X and their predictive value in glioblastoma.

Breznik B, Limback C, Porcnik A, Blejec A, Krajnc MK, Bosnjak R, Kos J, Van Noorden CJF, Lah TT.

Radiol Oncol. 2018 Oct 18;52(4):433-442. doi: 10.2478/raon-2018-0040.

14.

A road map for prioritizing warheads for cysteine targeting covalent inhibitors.

Ábrányi-Balogh P, Petri L, Imre T, Szijj P, Scarpino A, Hrast M, Mitrović A, Fonovič UP, Németh K, Barreteau H, Roper DI, Horváti K, Ferenczy GG, Kos J, Ilaš J, Gobec S, Keserű GM.

Eur J Med Chem. 2018 Dec 5;160:94-107. doi: 10.1016/j.ejmech.2018.10.010. Epub 2018 Oct 6.

PMID:
30321804
15.

Aflatoxins in maize harvested in the Republic of Serbia over the period 2012-2016.

Kos J, Janić Hajnal E, Šarić B, Jovanov P, Mandić A, Đuragić O, Kokić B.

Food Addit Contam Part B Surveill. 2018 Dec;11(4):246-255. doi: 10.1080/19393210.2018.1499675. Epub 2018 Aug 29.

PMID:
30157711
16.

Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides.

Pospisilova S, Kos J, Michnova H, Kapustikova I, Strharsky T, Oravec M, Moricz AM, Bakonyi J, Kauerova T, Kollar P, Cizek A, Jampilek J.

Int J Mol Sci. 2018 Aug 7;19(8). pii: E2318. doi: 10.3390/ijms19082318.

17.

NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.

Jewett A, Kos J, Fong Y, Ko MW, Safaei T, Perišić Nanut M, Kaur K.

Semin Cancer Biol. 2018 Dec;53:178-188. doi: 10.1016/j.semcancer.2018.08.001. Epub 2018 Aug 3. Review.

PMID:
30081230
18.

Cysteine cathepsins: Their biological and molecular significance in cancer stem cells.

Pišlar A, Jewett A, Kos J.

Semin Cancer Biol. 2018 Dec;53:168-177. doi: 10.1016/j.semcancer.2018.07.010. Epub 2018 Jul 29. Review.

PMID:
30063965
19.

Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches.

Breznik B, Limbaeck Stokin C, Kos J, Khurshed M, Hira VVV, Bošnjak R, Lah TT, Van Noorden CJF.

J Mol Histol. 2018 Oct;49(5):481-497. doi: 10.1007/s10735-018-9787-y. Epub 2018 Jul 25.

20.

The transcription factor C/EBP α controls the role of cystatin F during the differentiation of monocytes to macrophages.

Dautović E, Perišić Nanut M, Softić A, Kos J.

Eur J Cell Biol. 2018 Sep;97(7):463-473. doi: 10.1016/j.ejcb.2018.07.002. Epub 2018 Jul 17.

PMID:
30033148
21.

Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.

Knez D, Coquelle N, Pišlar A, Žakelj S, Jukič M, Sova M, Mravljak J, Nachon F, Brazzolotto X, Kos J, Colletier JP, Gobec S.

Eur J Med Chem. 2018 Aug 5;156:598-617. doi: 10.1016/j.ejmech.2018.07.033. Epub 2018 Jul 19.

PMID:
30031971
22.

Investigation of Hydro-Lipophilic Properties of N-Alkoxyphenylhydroxynaphthalenecarboxamides †.

Kapustikova I, Bak A, Gonec T, Kos J, Kozik V, Jampilek J.

Molecules. 2018 Jul 4;23(7). pii: E1635. doi: 10.3390/molecules23071635.

23.

The Antimicrobial Activity of Annona emarginata (Schltdl.) H. Rainer and Most Active Isolated Compounds against Clinically Important Bacteria.

Dolab JG, Lima B, Spaczynska E, Kos J, Cano NH, Feresin G, Tapia A, Garibotto F, Petenatti E, Olivella M, Musiol R, Jampilek J, Enriz RD.

Molecules. 2018 May 16;23(5). pii: E1187. doi: 10.3390/molecules23051187.

24.

Cystatin F as a regulator of immune cell cytotoxicity.

Kos J, Nanut MP, Prunk M, Sabotič J, Dautović E, Jewett A.

Cancer Immunol Immunother. 2018 Dec;67(12):1931-1938. doi: 10.1007/s00262-018-2165-5. Epub 2018 May 10. Review.

PMID:
29748898
25.

Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy.

Kaur K, Nanut MP, Ko MW, Safaie T, Kos J, Jewett A.

Curr Opin Immunol. 2018 Apr;51:170-180. doi: 10.1016/j.coi.2018.03.022. Epub 2018 Apr 10. Review.

PMID:
29653339
26.

Cathepsin B inhibitors: Further exploration of the nitroxoline core.

Sosič I, Mitrović A, Ćurić H, Knez D, Brodnik Žugelj H, Štefane B, Kos J, Gobec S.

Bioorg Med Chem Lett. 2018 Apr 15;28(7):1239-1247. doi: 10.1016/j.bmcl.2018.02.042. Epub 2018 Feb 23.

PMID:
29503024
27.

Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents.

Panek D, Więckowska A, Jończyk J, Godyń J, Bajda M, Wichur T, Pasieka A, Knez D, Pišlar A, Korabecny J, Soukup O, Sepsova V, Sabaté R, Kos J, Gobec S, Malawska B.

ACS Chem Neurosci. 2018 May 16;9(5):1074-1094. doi: 10.1021/acschemneuro.7b00461. Epub 2018 Feb 1.

PMID:
29345897
28.

The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.

Košak U, Brus B, Knez D, Žakelj S, Trontelj J, Pišlar A, Šink R, Jukič M, Živin M, Podkowa A, Nachon F, Brazzolotto X, Stojan J, Kos J, Coquelle N, Sałat K, Colletier JP, Gobec S.

J Med Chem. 2018 Jan 11;61(1):119-139. doi: 10.1021/acs.jmedchem.7b01086. Epub 2017 Dec 22.

PMID:
29227101
29.

Reliability of CKD-EPI predictive equation in estimating chronic kidney disease prevalence in the Croatian endemic nephropathy area.

Fuček M, Dika Ž, Karanović S, Vuković Brinar I, Premužić V, Kos J, Cvitković A, Mišić M, Samardžić J, Rogić D, Jelaković B.

Biochem Med (Zagreb). 2018 Feb 15;28(1):010701. doi: 10.11613/BM.2018.010701. Epub 2017 Nov 24.

30.

Cystatin F Affects Natural Killer Cell Cytotoxicity.

Perišić Nanut M, Sabotič J, Švajger U, Jewett A, Kos J.

Front Immunol. 2017 Nov 13;8:1459. doi: 10.3389/fimmu.2017.01459. eCollection 2017.

31.

Halogenated 1-Hydroxynaphthalene-2-Carboxanilides Affecting Photosynthetic Electron Transport in Photosystem II.

Gonec T, Kos J, Pesko M, Dohanosova J, Oravec M, Liptaj T, Kralova K, Jampilek J.

Molecules. 2017 Oct 12;22(10). pii: E1709. doi: 10.3390/molecules22101709.

32.

Aqueous Extracts of Wild Mushrooms Show Antimicrobial and Antiadhesion Activities against Bacteria and Fungi.

Klančnik A, Megušar P, Sterniša M, Jeršek B, Bucar F, Smole Možina S, Kos J, Sabotič J.

Phytother Res. 2017 Dec;31(12):1971-1976. doi: 10.1002/ptr.5934. Epub 2017 Sep 28.

PMID:
28960508
33.

Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo.

Mitrović A, Sosič I, Kos Š, Tratar UL, Breznik B, Kranjc S, Mirković B, Gobec S, Lah T, Serša G, Kos J.

Oncotarget. 2017 Jul 17;8(35):59136-59147. doi: 10.18632/oncotarget.19296. eCollection 2017 Aug 29.

34.

Identification and characterization of the novel reversible and selective cathepsin X inhibitors.

Fonović UP, Mitrović A, Knez D, Jakoš T, Pišlar A, Brus B, Doljak B, Stojan J, Žakelj S, Trontelj J, Gobec S, Kos J.

Sci Rep. 2017 Sep 13;7(1):11459. doi: 10.1038/s41598-017-11935-1.

35.

Mapping the aberrations of a wide-field spectrograph using a photonic comb.

Bland-Hawthorn J, Kos J, Betters CH, De Silva G, O'Byrne J, Patterson R, Leon-Saval SG.

Opt Express. 2017 Jul 10;25(14):15614-15623. doi: 10.1364/OE.25.015614.

PMID:
28789076
36.

Photosynthesis-Inhibiting Activity of 1-[(2-Chlorophenyl)carbamoyl]- and 1-[(2-Nitrophenyl)carbamoyl]naphthalen-2-yl Alkylcarbamates.

Gonec T, Stranik J, Pesko M, Kos J, Oravec M, Kralova K, Jampilek J.

Molecules. 2017 Jul 17;22(7). pii: E1199. doi: 10.3390/molecules22071199.

37.

Higher fungi are a rich source of L-amino acid oxidases.

Žun G, Kos J, Sabotič J.

3 Biotech. 2017 Jul;7(3):230. doi: 10.1007/s13205-017-0813-7. Epub 2017 Jul 6.

38.

Aflatoxins contamination of maize in Serbia: the impact of weather conditions in 2015.

Janić Hajnal E, Kos J, Krulj J, Krstović S, Jajić I, Pezo L, Šarić B, Nedeljković N.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2017 Nov;34(11):1999-2010. doi: 10.1080/19440049.2017.1331047. Epub 2017 Jul 11.

PMID:
28540749
39.

Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells.

Mitrović A, Pečar Fonović U, Kos J.

Eur J Cell Biol. 2017 Sep;96(6):622-631. doi: 10.1016/j.ejcb.2017.04.003. Epub 2017 Apr 25.

PMID:
28495172
40.

Fungal lectin MpL enables entry of protein drugs into cancer cells and their subcellular targeting.

Å Urga S, Nanut MP, Kos J, Sabotič J.

Oncotarget. 2017 Apr 18;8(16):26896-26910. doi: 10.18632/oncotarget.15849.

41.

Trypsin-specific Inhibitors from the Macrolepiota procera, Armillaria mellea and Amanita phalloides wild mushrooms.

Lukanc T, Brzin J, Kos J, Sabotič J.

Acta Biochim Pol. 2017;64(1):21-24. doi: 10.18388/abp.2015_1187. Epub 2017 Mar 3.

42.

The influence of macro- and microelements in seminal plasma on diluted boar sperm quality.

Pipan MZ, Mrkun J, Strajn BJ, Vrtač KP, Kos J, Pišlar A, Zrimšek P.

Acta Vet Scand. 2017 Feb 10;59(1):11. doi: 10.1186/s13028-017-0279-y.

43.

Medicinal Properties of the Genus Clitocybe and of Lectins from the Clouded Funnel Cap Mushroom, C. nebularis (Agaricomycetes): A Review.

Pohleven J, Kos J, Sabotic J.

Int J Med Mushrooms. 2016;18(11):965-975. doi: 10.1615/IntJMedMushrooms.v18.i11.20. Review.

PMID:
28008809
44.

Comparison of ELISA, HPLC-FLD and HPLC-MS/MS Methods for Determination of Aflatoxin M1 in Natural Contaminated Milk Samples.

Kos J, Janić Hajnal E, Jajić I, Krstović S, Mastilović J, Šarić B, Jovanov P.

Acta Chim Slov. 2016 Dec;63(4):747-756.

PMID:
28004091
45.

Development of an in-vivo active reversible butyrylcholinesterase inhibitor.

Košak U, Brus B, Knez D, Šink R, Žakelj S, Trontelj J, Pišlar A, Šlenc J, Gobec M, Živin M, Tratnjek L, Perše M, Sałat K, Podkowa A, Filipek B, Nachon F, Brazzolotto X, Więckowska A, Malawska B, Stojan J, Raščan IM, Kos J, Coquelle N, Colletier JP, Gobec S.

Sci Rep. 2016 Dec 21;6:39495. doi: 10.1038/srep39495.

46.

N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.

Košak U, Knez D, Coquelle N, Brus B, Pišlar A, Nachon F, Brazzolotto X, Kos J, Colletier JP, Gobec S.

Bioorg Med Chem. 2017 Jan 15;25(2):633-645. doi: 10.1016/j.bmc.2016.11.032. Epub 2016 Nov 19.

PMID:
27908752
47.

Inhibition of cathepsin X reduces the strength of microglial-mediated neuroinflammation.

Pišlar A, Božić B, Zidar N, Kos J.

Neuropharmacology. 2017 Mar 1;114:88-100. doi: 10.1016/j.neuropharm.2016.11.019. Epub 2016 Nov 23.

PMID:
27889490
48.

The response of aminopeptidases of Phaseolus vulgaris to drought depends on the developmental stage of the leaves.

Budič M, Cigić B, Šoštarič M, Sabotič J, Meglič V, Kos J, Kidrič M.

Plant Physiol Biochem. 2016 Dec;109:326-336. doi: 10.1016/j.plaphy.2016.10.007. Epub 2016 Oct 13.

PMID:
27783982
49.

Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity.

Mitrović A, Kljun J, Sosič I, Gobec S, Turel I, Kos J.

Dalton Trans. 2016 Nov 14;45(42):16913-16921. Epub 2016 Sep 30.

PMID:
27711842
50.

Nanoparticle Based Delivery of Protease Inhibitors to Cancer Cells.

Prunk M, Kos J.

Curr Med Chem. 2017;24(42):4816-4837. doi: 10.2174/0929867323666160922162811. Review.

PMID:
27667137

Supplemental Content

Support Center